墨菲美国 MUSA 深 沪
等待开盘 04-06 09:30:00 美东时间
502.41
+7.590
+1.53%
华盛通- 最 高507.29
- 今 开502.00
- 成交量 24.83万股
- 最 低 496.10
- 昨 收 494.82
- 总市值 92.95亿
- 52周最高 520.80
- 市盈率 静 20.85
- 换手率 1.34%
- 52周最低 343.4401
- 委 比 0.00%
- 总股本 1850.02万
- 历史最高 558.30
- 量 比 0.70
- 振 幅 2.26%
- 历史最低 27.44
- 每 手 1
- 风险率 39.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
Small Caps Rally, Oil Sinks 8% After Trump's 5-Day Iran Strike Pause: What's Moving Markets Monday?
Iran denies talks as Trump's strike pause sparks relief rally, oil plunge, and surge in beaten-down global equities.
03-24 01:18
Stocks Tumble, Crude Tops $91 For First Time Since October 2023: What's Moving Markets Friday?
U.S. equities fell sharply Friday as a weak jobs report and surging crude oil reignited stagflation fears.
03-07 02:18
美股大行评级 | 遭多家大行下调目标价！亚马逊、Affirm、Roblox、汤森路透、Doximity、OneMain、Atlassian、Peloton等等
今日重点评级关注：HC Wainwright & Co.：维持NovaBridge Biosciences"买入"评级，目标价从7美元升至9美元；Truist Securities：维持Reddit"买入"评级，目标价从270美元升至275美元
02-09 14:37
美股大行评级 | 谷歌绩后获14家大行上调目标价；Arm、高通、波士顿科学、艾可菲、Snap、优步遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Wave Life Sciences Ltd."超配"评级，目标价从34美元升至41美元；Piper Sandler：维持Replimune Group"超配"评级，目标价从13美元升至14美元
02-06 16:52
财报速睇 | 墨菲美国 2025财年Q4营收47.44亿美元，同比增长0.7%；归母净利润1.42亿美元，同比下滑0.4%
华盛资讯2月6日讯，墨菲美国公布2025财年Q4业绩，公司Q4营收47.44亿美元，同比增长0.7%，归母净利润1.42亿美元，同比下滑0.4%。
02-06 03:02
RBC Capital Maintains Sector Perform on Murphy USA, Lowers Price Target to $445
RBC Capital analyst Irene Nattel maintains Murphy USA (NYSE:MUSA) with a Sector Perform and lowers the price target from $467 to $445.
02-05 23:35
Murphy USA: Q4 Earnings Insights
Murphy USA (NYSE:MUSA) just disclosed its Q4 earnings on Wednesday, February 4,...
02-05 05:32
Murphy USA Q4 EPS $7.53 Beats $6.56 Estimate, Sales $4.743B Miss $4.855B Estimate
Murphy USA (NYSE:MUSA) reported quarterly earnings of $7.53 per share which beat the analyst consensus estimate of $6.56 by 14.8 percent. This is a 8.19 percent increase over earnings of $6.96 per share from the same
02-05 05:32
Earnings Scheduled For February 4, 2026
Companies Reporting Before The Bell • Oaktree Specialty Lending (NASDAQ:OCSL) i...
02-04 19:11
